177 related articles for article (PubMed ID: 8206494)
1. Apoptosis and cancer.
Green DR; Bissonnette RP; Cotter TG
Important Adv Oncol; 1994; ():37-52. PubMed ID: 8206494
[No Abstract] [Full Text] [Related]
2. [Cancer cells. Genetic anomalies (oncogenes and anti-oncogenes), growth factors, apoptosis and dissemination, prognostic impact].
Blay JY; Puisieux A
Rev Prat; 2000 May; 50(10):1135-44. PubMed ID: 10905101
[No Abstract] [Full Text] [Related]
3. Oncogenes, growth regulation, and cancer.
Tronick SR; Aaronson SA
Adv Second Messenger Phosphoprotein Res; 1988; 21():201-14. PubMed ID: 3137959
[No Abstract] [Full Text] [Related]
4. p53 and response to chemotherapy and radiotherapy.
Ruley HE
Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
[No Abstract] [Full Text] [Related]
5. [Cell cycle and carcinogenesis].
Solé Balcells F
Ann Urol (Paris); 1995; 29(5):271-9. PubMed ID: 8638907
[TBL] [Abstract][Full Text] [Related]
6. Cellular epigenetics and the origin of cancer.
Cuthill S
Bioessays; 1994 Jun; 16(6):393-4. PubMed ID: 8080428
[No Abstract] [Full Text] [Related]
7. [Oncogenes--"reckless drivers" on signal pathways controlling cell division].
Johansen T; Bjørkøy G
Tidsskr Nor Laegeforen; 1998 May; 118(12):1880-5. PubMed ID: 9638058
[TBL] [Abstract][Full Text] [Related]
8. [Cell and disease. X. disorders in signal transduction: dysregulation of cell growth in cancer].
Zwarthoff EC
Ned Tijdschr Geneeskd; 1993 Nov; 137(45):2310-4. PubMed ID: 8255337
[No Abstract] [Full Text] [Related]
9. Of sea urchins and worms: development and cancer.
Knudson AG
Cell Death Differ; 2004 Jan; 11(1):11-2. PubMed ID: 14685167
[No Abstract] [Full Text] [Related]
10. Senescence, apoptosis and therapy--cutting the lifelines of cancer.
Schmitt CA
Nat Rev Cancer; 2003 Apr; 3(4):286-95. PubMed ID: 12671667
[TBL] [Abstract][Full Text] [Related]
11. In vivo models for studying the role of autocrine or paracrine growth factors in hematologic malignancies.
Soma T; Dunbar CE
Exp Hematol; 1995 May; 23(5):385-8. PubMed ID: 7720810
[No Abstract] [Full Text] [Related]
12. [Apoptosis--programmed cell death].
Borner M
Ther Umsch; 1998 Jul; 55(7):459-61. PubMed ID: 9702120
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1.
Dolnikov A; Ward RL; Hawkins NJ; Symonds G
Oncogene; 1996 Mar; 12(6):1189-98. PubMed ID: 8649820
[TBL] [Abstract][Full Text] [Related]
14. Malignancy: an evolving definition of a cancer cell.
Williams JL
Clin Lab Sci; 2002; 15(1):37-43. PubMed ID: 12778955
[No Abstract] [Full Text] [Related]
15. Origin and reversibility of malignancy.
Sachs L
Carcinog Compr Surv; 1985; 10():23-33. PubMed ID: 3904990
[No Abstract] [Full Text] [Related]
16. Comments on future developments of cancer therapy taking into consideration tumor biology and kinetics. Part I.
Ragaz J
Prog Clin Biol Res; 1990; 354A():379-85. PubMed ID: 2247500
[No Abstract] [Full Text] [Related]
17. Perspectives on clonogenic tumor cells, stem cells, and oncogenes.
Buick RN; Pollak MN
Cancer Res; 1984 Nov; 44(11):4909-18. PubMed ID: 6386145
[No Abstract] [Full Text] [Related]
18. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
19. [Tumors and evolution].
Kozlov AP
Vopr Onkol; 2008; 54(6):695-705. PubMed ID: 19241842
[No Abstract] [Full Text] [Related]
20. Inflammation and cancer: the oncogene-driven connection.
Borrello MG; Degl'Innocenti D; Pierotti MA
Cancer Lett; 2008 Aug; 267(2):262-70. PubMed ID: 18502035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
